Inventor
SONG GENGSHEN
CN7 patents
⚠️ This page may combine multiple inventors who share the name “SONG GENGSHEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HANGZHOU TIANLONG PHARMACEUTICAL CO LTD
4 patentsUS12171876B2Dec 24, 2024
Cationic lipid compound, composition containing same and use thereof
HANGZHOU TIANLONG PHARMACEUTICAL CO LTD2 citations64
US12551500B2Feb 17, 2026
C6′-substituted locked nucleic acid-modified cap analog and use thereof
HANGZHOU TIANLONG PHARMACEUTICAL CO LTD0 citations55
US12514920B1Jan 6, 2026
Respiratory syncytial virus mRNA vaccine, and preparation method therefor and use thereof
HANGZHOU TIANLONG PHARMACEUTICAL CO LTD0 citations43
US12478669B1Nov 25, 2025
Herpes zoster mRNA vaccine, preparation method therefor, and use thereof
HANGZHOU TIANLONG PHARMACEUTICAL CO LTD0 citations42
BEIJING YOUCARE KECHUANG PHARMACEUTICAL TECH CO LTD
3 patentsUS12576099B2Mar 17, 2026
Ribose-modified cap analog and use thereof
BEIJING YOUCARE KECHUANG PHARMACEUTICAL TECH CO LTD0 citations57
US12485170B2Dec 2, 2025
Lipid composition targeting antigen-presenting cells and use thereof
BEIJING YOUCARE KECHUANG PHARMACEUTICAL TECH CO LTD0 citations55
US12545637B2Feb 10, 2026
Extrahepatic targeted cationic lipid compound with high efficiency and low toxicity and its composition
BEIJING YOUCARE KECHUANG PHARMACEUTICAL TECH CO LTD0 citations54